Inapill

Inapill is honored to be selected to the California Life Sciences (CLS) FAST California advisory program Spring 2025 cohort along with the other incredible early-stage companies. The FAST program has an extremely impressive alumni list of start-ups that have successfully raised capital to support their development of groundbreaking therapies to help patients. We will use this opportunity, and the kind mentorship of the FAST California advisors, as a springboard to meet our goal of developing improved treatments for patients suffering from inflammatory and autoimmune diseases.

It was a pleasure?sharing our work at Inapill on 1st-in-class small molecule approaches to targeting #immunometabolism for treatment of inflammatory and autoimmune disease with Sillicon?Valley and Japanese VC/CVC leaders last Friday at Salesforce Tower. Thank you Bakar Labs for the showcase & networking opportunity alongside our Bakar Bio Labs and JETRO Startup colleagues! Many thanks Satsuki Ibaraki and Riley Hummel for the photos

So great to have our JETRO visitors from Japan here for the second of two 5-week stints. Wrapped up at the top of the Salesforce Tower in SF, with a pitch session including several Bakar Labs tenants. The views! Thanks for all the energy and warmth you brought, Yo (Max) Amakusa Kazuyoshi MIYAWAKI Kazuhiro Takahashi Lucas Mixich Kensuke Kato. Amin Zargar Dana Foss, PhD Anders Naar Catherine "Katy" Digovich Greg Timblin Jeremy Alberga Ensanté JETRO Startup

We're excited to be selected to meet with multiple VC and industry leaders as part of the Investor Partnering Forum at the CLS #InnovationShowcase next week! Looking forward to sharing our vision on novel ways to target #immunometabolism in inflammatory and autoimmune diseases.